Milestone Scientific Inc.
MLSS · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $9 | $10 | $9 | $10 |
| % Growth | -12.2% | 11.6% | -14.5% | – |
| Cost of Goods Sold | $2 | $3 | $4 | $4 |
| Gross Profit | $6 | $7 | $5 | $6 |
| % Margin | 74.6% | 69.1% | 55.7% | 61.3% |
| R&D Expenses | $1 | $1 | $1 | $1 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $12 | $13 | $13 | $13 |
| Operating Expenses | $13 | $14 | $14 | $14 |
| Operating Income | -$7 | -$7 | -$9 | -$7 |
| % Margin | -78.3% | -72.3% | -100.2% | -71.6% |
| Other Income/Exp. Net | $2 | $0 | $0 | $1 |
| Pre-Tax Income | -$5 | -$7 | -$9 | -$7 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$5 | -$7 | -$9 | -$7 |
| % Margin | -54.6% | -70.5% | -98.9% | -66.2% |
| EPS | -0.059 | -0.095 | -0.12 | -0.1 |
| % Growth | 37.9% | 20.7% | -20% | – |
| EPS Diluted | -0.059 | -0.095 | -0.12 | -0.1 |
| Weighted Avg Shares Out | 80 | 73 | 71 | 69 |
| Weighted Avg Shares Out Dil | 80 | 73 | 71 | 69 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$7 | -$7 | -$9 | -$7 |
| % Margin | -77.9% | -71.7% | -99.5% | -70.9% |